Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.52% Nasdaq Down1.11%

Celldex Therapeutics, Inc. (CLDX)

-NMS

12.53 Down 0.08(0.63%) 4:00PM EDT|After Hours : 12.64 Up 0.11 (0.89%) 4:11PM EDT

Add to Portfolio
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Net Income (59,123) (44,799) (2,533)
Operating Activities, Cash Flows Provided By or Used In
Depreciation2,477  4,178  5,847  
Adjustments To Net Income2,444  2,596  3,488  
Changes In Accounts Receivables126  154  220  
Changes In Liabilities4,356  1,938  (42,440)
Changes In Inventories -   -   -  
Changes In Other Operating Activities(62)275  5,046  
Total Cash Flow From Operating Activities (49,782) (35,658) (30,372)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(303)(509)(2,100)
Investments(16,895)(1,714)(14,139)
Other Cash flows from Investing Activities218  68  77  
Total Cash Flows From Investing Activities (16,980) (2,155) (16,162)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock83,784  36,023  1,014  
Net Borrowings(3,971)(7,503)10,000  
Other Cash Flows from Financing Activities(55)(86)(197)
Total Cash Flows From Financing Activities 79,758   28,434   10,817  
Effect Of Exchange Rate Changes2  (9)2  
Change In Cash and Cash Equivalents 12,998   (9,388) (35,715)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.